Abstract:Background/Objectives: Osteoarthritis (OA) is a prevalent and debilitating joint disorder characterized by progressive cartilage degradation and inflammation, for which traditional treatments offer only symptomatic relief without halting disease progression. Exosomes, cell-free vesicles derived from mesenchymal stem cells, have emerged as a promising alternative therapy owing to their regenerative and anti-inflammatory properties. Methods: This review synthesizes findings from recent studies (2017–2023) on the therapeutic potential of exosomes in OA treatment, highlighting their ability to modulate the joint microenvironment, reduce inflammation, and promote cartilage repair by delivering bioactive molecules such as cytokines, growth factors, and regulatory ribonucleic acids. Results: We explore the integration of exosomes with biomaterials, such as hydrogels and scaffolds, to enhance their delivery and therapeutic efficacy, and we address the critical challenges associated with their clinical application, including standardization of isolation and characterization methods, scalability of production, mechanistic understanding, and long-term safety. Despite these challenges, exosome-based therapies offer several advantages over traditional and cell-based treatments, including lower immunogenicity, ease of handling, and targeted delivery of therapeutic agents to damaged tissues. Conclusions: We provide an analytical perspective on the current state of exosome research in OA, emphasizing the need for standardized production methods, deeper mechanistic insights, and rigorous long-term safety assessments. Future directions should focus on optimizing delivery systems, exploring personalized medicine approaches, and conducting comparative effectiveness studies to fully realize the potential of exosome therapies for OA treatment. Addressing these gaps will be crucial for translating exosome therapies from bench to bedside and achieving a transformative impact on OA management.

Roles of Exosomes from Mesenchymal Stem Cells in Treating Osteoarthritis

The Interactions Between Extracellular Vesicles and Mesenchymal Stem Cells: Their Potential Roles in Osteoarthritis Development and Cartilage Repair

Exosomes from Embryonic Mesenchymal Stem Cells Alleviate Osteoarthritis Through Balancing Synthesis and Degradation of Cartilage Extracellular Matrix

Mesenchymal Stem Cell-Derived Exosomes as a Treatment Option for Osteoarthritis

Enhancement of the therapeutic efficacy of mesenchymal stem cell-derived exosomes in osteoarthritis

Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis?

Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis

Exosomes derived from MSC as drug system in osteoarthritis therapy

The role and therapeutic potential of MSC-derived exosomes in osteoarthritis

The role of exosomes and their enhancement strategies in the treatment of osteoarthritis

Roles of Microenvironment on Mesenchymal Stem Cells Therapy for Osteoarthritis

Mesenchymal Stem Cell-Derived Exosomes and Their Therapeutic Potential for Osteoarthritis

Exosomes in osteoarthritis: Updated insights on pathogenesis, diagnosis, and treatment

Extracellular vesicles: Potential role in osteoarthritis regenerative medicine

Research Progress of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Osteoarthritis

Exosome-Mediated Drug Delivery for Cell-Free Therapy of Osteoarthritis

Therapeutic effects of bone marrow mesenchymal stem cells‐derived exosomes on osteoarthritis

Extracellular Vesicles from Mesenchymal Stem Cells as Potential Treatments for Osteoarthritis

Advancing Osteoarthritis Treatment: The Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes and Biomaterial Integration

Harnessing the potential of mesenchymal stem cells-derived exosomes in degenerative diseases

Research progress in the use of mesenchymal stem cells and their derived exosomes in the treatment of osteoarthritis